Susquehanna International Group’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,610
| Closed | -$13.3K | – | 6920 |
|
|
2025
Q1 | $13.3K | Buy |
25,610
+1,808
| +8% | +$940 | ﹤0.01% | 6205 |
|
|
2024
Q4 | $12.1K | Buy |
+23,802
| New | +$12.1K | ﹤0.01% | 6035 |
|
|
2024
Q1 | – | Sell |
-275
| Closed | -$2.97K | – | 6219 |
|
|
2023
Q4 | $2.97K | Buy |
+275
| New | +$2.97K | ﹤0.01% | 5798 |
|
|
2023
Q2 | – | Sell |
-295
| Closed | -$6.93K | – | 6183 |
|
|
2023
Q1 | $6.93K | Sell |
295
-286
| -49% | -$6.71K | ﹤0.01% | 5761 |
|
|
2022
Q4 | $14.5K | Buy |
+581
| New | +$14.5K | ﹤0.01% | 5419 |
|
|
2022
Q1 | – | Sell |
-1,191
| Closed | -$60K | – | 6246 |
|
|
2021
Q4 | $60K | Buy |
+1,191
| New | +$60K | ﹤0.01% | 5429 |
|
|
2021
Q3 | – | Sell |
-239
| Closed | -$9K | – | 5798 |
|
|
2021
Q2 | $9K | Sell |
239
-6,366
| -96% | -$240K | ﹤0.01% | 5254 |
|
|
2021
Q1 | $347K | Buy |
6,605
+6,065
| +1,123% | +$319K | ﹤0.01% | 4221 |
|
|
2020
Q4 | $37K | Sell |
540
-753
| -58% | -$51.6K | ﹤0.01% | 4645 |
|
|
2020
Q3 | $50K | Buy |
+1,293
| New | +$50K | ﹤0.01% | 4218 |
|
|
2020
Q2 | – | Sell |
-25,828
| Closed | -$775K | – | 4664 |
|
|
2020
Q1 | $775K | Buy |
25,828
+14,122
| +121% | +$424K | ﹤0.01% | 2332 |
|
|
2019
Q4 | $1.33M | Buy |
+11,706
| New | +$1.33M | ﹤0.01% | 1669 |
|
|
2019
Q3 | – | Sell |
-1,803
| Closed | -$77K | – | 4813 |
|
|
2019
Q2 | $77K | Sell |
1,803
-3,353
| -65% | -$143K | ﹤0.01% | 4205 |
|
|
2019
Q1 | $281K | Buy |
+5,156
| New | +$281K | ﹤0.01% | 2308 |
|
|
2018
Q2 | – | Sell |
-369
| Closed | -$14K | – | 4296 |
|
|
2018
Q1 | $14K | Buy |
+369
| New | +$14K | ﹤0.01% | 3252 |
|
|
2017
Q2 | – | Sell |
-693
| Closed | -$96K | – | 4046 |
|
|
2017
Q1 | $96K | Buy |
+693
| New | +$96K | ﹤0.01% | 2980 |
|